-
Start Preamble
Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 16, 2007, Cody Laboratories, 601 Yellowstone Avenue, Cody, Wyoming 82414, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Codeine (9050) II Ecgonine (9180) II Hydrocodone (9193) II Morphine (9300) II The company plans on manufacturing the listed controlled substances in bulk for sale to its customers.
Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, VA 22152; and must be filed no later than January 15, 2008.
Start SignatureStart Printed Page 64678End Signature End PreambleDated: November 6, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E7-22515 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 11/16/2007
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- E7-22515
- Pages:
- 64677-64678 (2 pages)
- PDF File:
- e7-22515.pdf